Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

This study is ongoing, but not recruiting participants.

Study NCT00004689 Information provided by FDA Office of Orphan Products Development

First Received: February 24, 2000 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given